GIST-harboring primary KIT exon 13 or exon 17 mutations (encoding the ATP-binding site and activation loop, respectively) and other exons occur in less than 5% of GIST cases, and are mostly resistant to IM [1,16]. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.